These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1247198)

  • 21. Bacteriologic and vaccination studies in a field epizootic of infectious bovine keratoconjunctivitis in calves.
    Arora AK; Killinger AH; Mansfield ME
    Am J Vet Res; 1976 Jul; 37(7):803-5. PubMed ID: 937804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infectious bovine keratoconjunctivitis: evidence for general immunity.
    Kopecky KE; Pugh GW; McDonald TJ
    Am J Vet Res; 1983 Feb; 44(2):260-2. PubMed ID: 6830015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimentally induced infectious bovine keratoconjunctivitis: vaccination with nonviable Moraxella bovis culture.
    Hughes DE; Pugh GW
    Am J Vet Res; 1972 Dec; 33(12):2475-9. PubMed ID: 4641206
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Bonifacio RG; Ball LM; Hess JF
    Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Moraxella bovis antibodies in infectious bovine keratoconjunctivitis by a passive hemagglutination test.
    Arora AK; Killinger AH; Myers WL
    Am J Vet Res; 1976 Dec; 37(12):1489-92. PubMed ID: 999074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis.
    Lepper AW
    Aust Vet J; 1988 Oct; 65(10):310-6. PubMed ID: 2904257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of aflatoxin ingestion on the development of Moraxella bovis infectious bovine keratoconjunctivitis.
    Pugh GW; Richard JL; Kopecky KE; McDonald TJ
    Cornell Vet; 1984 Apr; 74(2):96-110. PubMed ID: 6467950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infectious bovine keratoconjunctivitis II. Antibodies in lacrimal secretions of cattle naturally or experimentally infected with Moraxella bovis.
    Nayar PS; Saunders JR
    Can J Comp Med; 1975 Jan; 39(1):32-40. PubMed ID: 803398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme-linked immunosorbent assay for measurement of anti-Moraxella bovis antibodies.
    Bishop B; Schurig GG; Troutt HF
    Am J Vet Res; 1982 Aug; 43(8):1443-5. PubMed ID: 7049023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA.
    McConnel CS; Shum L; Gleeson BL; House JK
    Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of a Moraxella bovis bacterin containing attachment and cornea-degrading enzyme antigens.
    Gerber JD; Selzer NL; Sharpee RL; Beckenhauer WH
    Vet Immunol Immunopathol; 1988 Feb; 18(1):41-52. PubMed ID: 3376421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serologic and protective characterization of Moraxella bovis pili.
    Lehr C; Jayappa HG; Goodnow RA
    Cornell Vet; 1985 Oct; 75(4):484-92. PubMed ID: 2865080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bovine infectious keratoconjunctivitis: serological aspects of Moraxella bovis infection.
    Pugh GW; Hughes DE; McDonald TJ
    Can J Comp Med; 1971 Apr; 35(2):161-6. PubMed ID: 4253466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
    Angelos JA; Gohary KG; Ball LM; Hess JF
    Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of vaccination and treatment in controlling naturally occurring infectious bovine keratoconjunctivitis.
    Hughes DE; Kohlmeier RH; Pugh GW; Booth GD
    Am J Vet Res; 1979 Feb; 40(2):241-4. PubMed ID: 464360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in titres of Moraxella bovis-specific IgG in growing cattle.
    Maidment DC; Batty DL
    Br Vet J; 1986; 142(1):65-9. PubMed ID: 3947934
    [No Abstract]   [Full Text] [Related]  

  • 37. Laboratory model for infectious bovine keratoconjunctivitis: the pathogenicity of different strains of Moraxella bovis, pathology and ultrastructural observations.
    Chandler RL; Turfrey BA; Smith K
    Res Vet Sci; 1983 Nov; 35(3):277-84. PubMed ID: 6665310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotypic, phenotypic, and biological characteristics of Moraxella bovis.
    Schurig GG; Lightfoot DR; Troutt HF; Finkler BI
    Am J Vet Res; 1984 Jan; 45(1):35-9. PubMed ID: 6200014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenicity and immunogenicity of piliated and nonpiliated phases of Moraxella bovis in calves.
    Jayappa HG; Lehr C
    Am J Vet Res; 1986 Oct; 47(10):2217-21. PubMed ID: 2877604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infectious bovine keratoconjunctivitis: experimental induction of infection in calves with mycoplasmas and Moraxella bovis.
    Pugh GW; Hughes DE; Schulz VD
    Am J Vet Res; 1976 May; 37(5):493-5. PubMed ID: 1275332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.